A Cholecystokinin Receptor Antagonist Halts Nonalcoholic Steatohepatitis and Prevents Hepatocellular Carcinoma

ConclusionThese results support the novel role of CCK receptors in the pathogenesis of NASH and HCC.
Source: Digestive Diseases and Sciences - Category: Gastroenterology Source Type: research